德斯控股(08437.HK)拟1165.7万港元出售一间合营51%股权
格隆汇4月22日丨德斯控股(08437.HK)公吿,于2022年4月22日,买方皮肤医学有限公司与卖方德斯(香港)控股有限公司(公司的直接全资附属公司)订立买卖协议,据此,买方有条件同意向卖方收购而卖方有条件同意向买方出售╱转让皇仁医疗有限公司51%股份及股东贷款,总代价为1165.7万港元。
于公吿日期,合营公司皇仁医疗有限公司被确认为集团的合营公司,而其财务业绩、资产及负债尚未综合计入集团账目,于完成后,集团将不再直接或间接于合营公司集团持有任何权益。
集团为获新加坡衞生部正式认可的新加坡领先皮肤及外科专科诊所,透过一系列先进完善的医疗、外科、激光及美容疗程,针对影响皮肤、头发及指甲的各种皮肤问题提供既方便又全面的优质专业护理服务。
由于合营公司集团于注册成立日期(即2019年12月30日)至2020年12月31日期间及截至2021年12月31日止12个月因全球政治、经济紧张局势以及新型冠状病毒("COVID-19")爆发合共录得除税后亏损净额约26百万港元,预期出售事项将提升本集团的财务状况及流动性。
通过出售事项,集团的财务成本将大幅减少。由于于2021年12月31日集团于合营公司的投资并无账面值,预期出售事项对集团营运的影响微乎其微。于出售事项后,本集团的流动性及财务状况均将改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.